Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive
Κωνσταντίνα Κοντοπούλου, Alexandra Ainatzoglou, Christos T. Nakas, Athina Ifantidou, Georgia Goudi, Eleni Antoniadou, Vasilios Adamopoulos, Nikitas Papadopoulos, Georgios Papazisis
Topics & Concepts
ImmunogenicityTiterMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPharmacologyImmunologyAntibodyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies